# Retatrutide FAQ: approval, availability, price, trials and safety

> Answers to the most common UK questions about retatrutide: approval status, buying risks, timeline, efficacy, side effects and NHS access.

Canonical: https://yezz.co.uk/faq · Last reviewed: 2026-09-11 · Author: Nick Johnson, Independent Prescription Pricing Analyst, Medstack Ltd

## Key facts
- Approved in the UK? No — or anywhere else. It cannot legally be prescribed, sold or supplied.
- Can you buy it online? No — anything sold as retatrutide is unlicensed and illegal to supply.
- When will it reach the UK? Realistically 2028 privately, 2029+ on the NHS.
- How well does it work? 28.3% average weight loss at 80 weeks in TRIUMPH-1 (12 mg) — a trial average, not a guarantee.
- How much will it cost? Nobody knows — no price has been announced anywhere.

## Questions and answers

### Is retatrutide approved in the UK?

No. Retatrutide has no marketing authorisation from the MHRA — or from any regulator in any country. It cannot legally be prescribed, sold or supplied anywhere, and there is no legal UK stock. It is available only through clinical trials.

### Can I buy retatrutide online in the UK?

No. Anything sold as retatrutide — vials, pens, “research peptides” — is an unlicensed product of unknown content and purity, and supplying it for human use is illegal in the UK. There is no exception, and “for laboratory use only” labels change nothing about the risk. See our full warning page.

### When will retatrutide be available in the UK?

Realistically no earlier than 2028 through private pharmacies, and later on the NHS. Eli Lilly plans to file for US approval in Q1 2027; UK authorisation, NICE appraisal and NHS commissioning add years. Our UK timeline page maps every stage.

### How well does retatrutide work?

In the pivotal TRIUMPH-1 trial, participants on the 12 mg dose lost an average of 28.3% of body weight over 80 weeks, and 45.3% lost at least 30%. These are trial averages with intensive support, not individual guarantees — and cross-trial comparisons with Mounjaro or Wegovy need the still-unpublished head-to-head trial to be confirmed.

### What are the side effects of retatrutide?

So far, the pattern of the GLP-1 class: dose-related nausea, vomiting, diarrhoea and constipation, worst during dose increases, mostly settling with time. Trials also recorded a small early rise in heart rate that partially returned to baseline. Long-term safety data is still being gathered.

### Is retatrutide the same as Mounjaro?

No. Mounjaro is tirzepatide, a dual GIP/GLP-1 agonist that is MHRA-authorised and available in the UK. Retatrutide adds a third receptor (glucagon), is more effective in trials, and is not approved anywhere. Nobody should take “retatrutide” bought as a Mounjaro substitute.

### How much will retatrutide cost?

Nobody knows — no price has been announced in any country. Expect a premium launch price above existing medicines if it is authorised, with competition lowering it over time, based on how Mounjaro and Wegovy pricing developed in the UK. Any website quoting a retatrutide price today is inventing it.

### Can I join a retatrutide trial in the UK?

Possibly, if you meet the eligibility criteria of an actively recruiting TRIUMPH study. Recruitment runs through official registries such as ClinicalTrials.gov and NHS research networks — never through paid adverts or sellers. Genuine trials never charge participants for the medicine.

### Will retatrutide be available on the NHS?

Eventually, perhaps — but not soon. The pattern from tirzepatide suggests NICE appraisal and a phased NHS rollout starting years after authorisation, prioritising people at highest clinical need. On current timelines, NHS access from 2029 or later is the realistic projection.

### Is Yezz selling retatrutide or taking bookings?

No. Yezz sells nothing, takes no bookings, carries no affiliate links and accepts no pharmacy payment. It is an independent information site run by Medstack Ltd — the same team behind monj.co.uk — and its incentive is accuracy, because there is nothing here to buy.

---
Yezz is an independent UK information site run by Medstack Ltd. It sells nothing and provides general information, not medical advice.
Cite as: Nick Johnson. "Retatrutide FAQ: approval, availability, price, trials and safety". Yezz, 2026-09-11. https://yezz.co.uk/faq